Urinary Tract Carcinoma — Trials

Urinary Tract Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

852 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 326
Recruiting: 176
Ph III recruiting: 26
Growth YoY: +28.6%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 44.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (127)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06877676	Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use	approved for marketing	—	—	Janssen Research & Development, LLCINDUSTRY	0	Sep 25, 2026	clinicaltrials
NCT02589717	An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy	approved for marketing	—	—	Genentech, Inc.INDUSTRY	1	Nov 2, 2016